Mathieu Charvériat created Theranexus with Franck Mouthon in 2013 and has served as Chief Scientific Officer ever since. Mathieu is in charge of the discovery platform and non-clinical development of new drugs in the company. He earned a Ph.D in neurosciences and graduated from Ecole Polytechnique and Mines ParisTech.